Translate
Chemocentryx Inc.
About
Chemocentryx Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Oct 17 2022
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
Oct 5 2022
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Aug 24 2022
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
Jul 5 2022
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
May 31 2022
ChemoCentryx Announces Changes to its Board of Directors